Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Homeodomain-interacting protein kinase 3 (HIPK3) mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the HIPK3 transcript that governs the stability and translation of the HIPK3 protein (UniProt Q9H422). HIPK3 is a serine/threonine kinase involved in diverse cellular processes, including apoptosis, glucose metabolism, and the cell cycle. The 3′UTR serves as a primary docking site for various microRNAs (miRNAs), such as miR-193a-3p and miR-338-3p, which post-transcriptionally repress HIPK3 expression (PubMed: 25823897, 21880712). Dysregulation of this regulatory axis is implicated in several pathologies; for instance, reduced miRNA binding or 3′UTR mutations can lead to HIPK3 overexpression, promoting oncogenesis and chemoresistance in various cancers (PubMed: 25823897). In metabolic contexts, the HIPK3 3′UTR-miRNA interaction is essential for maintaining pancreatic beta-cell function and insulin secretion (PubMed: 21880712). Furthermore, the HIPK3 gene also produces a circular RNA (circHIPK3) that acts as a sponge for these same miRNAs, thereby indirectly protecting the mRNA 3′UTR from repression (PubMed: 30033884). Consequently, the HIPK3 mRNA 3′UTR is an emerging focal point for RNA-targeted therapeutic strategies, including the use of antisense oligonucleotides (ASOs) and miRNA mimics designed to modulate HIPK3 levels for treating cancer and metabolic disorders.
Binding of microRNA mimics or antisense oligonucleotides to the 3′UTR to induce mRNA degradation or prevent translation of the HIPK3 protein.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeodomain-interacting protein kinase 3 mRNA 3′ untranslated region (HIPK3 mRNA 3′UTR) (HIPK3 mRNA 3′UTR).